EVALUATION OF P16 AND MTAP IMMUNOHISTOCHEMICAL EXPRESSION AS SURROGATE MARKERS OF CDKN2A/B DELETION IN MENINGIOMAS

被引:0
|
作者
Ricci, A. A. [1 ,2 ]
Tampieri, C. [1 ,2 ]
Nozzoli, F. [3 ]
Buccoliero, A. M. [4 ]
Mangherini, L. [1 ,2 ]
di Cantogno, L. Verdun [5 ]
Osella-Abate, S. [5 ]
Pellerino, A. [6 ,7 ]
Bruno, F. [6 ,7 ]
Ruda, R. [6 ,7 ]
Garbossa, D. [2 ,8 ]
Massi, D. [3 ]
Cassoni, P. [1 ,2 ]
Bertero, L. [1 ,2 ]
机构
[1] Univ Turin, Pathol Unit, Dept Med Sci, Turin, Italy
[2] Citta Salute Sci Univ Hosp, Turin, Italy
[3] Univ Florence, Sect Anat Pathol, Dept Hlth Sci, Florence, Italy
[4] Meyer Childrens Hosp IRCCS, Pathol Unit, Florence, Italy
[5] Citta Salute Sci Univ Hosp, Mol Pathol Unit, Dept Lab Med, Turin, Italy
[6] Univ Turin, Div Neurooocol, Dept Neurosci Univ, Turin, Italy
[7] Univ Turin, City Hlth & Sci, Turin, Italy
[8] Univ Turin, Neurosurg Unit, Dept Neurosci, Turin, Italy
关键词
D O I
10.1093/neuonc/noad137.414
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P18.06.B
引用
收藏
页码:123 / 123
页数:1
相关论文
共 50 条
  • [1] Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas
    Maragkou, Theoni
    Reinhard, Stefan
    Jungo, Patric
    Pasquier, Baptiste
    Neuenschwander, Maja
    Schucht, Philippe
    Vassella, Erik
    Hewer, Ekkehard
    [J]. PATHOLOGY, 2023, 55 (04) : 466 - 477
  • [2] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, H.
    Ozkizilkaya, H.
    Ogunbona, O. Basit
    Toruner, G.
    Aung, P.
    Esquenazi, Y.
    DeMonte, F.
    Ballester, L.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546
  • [3] Comparing p16 and MTAP loss of expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma
    Vizcaino, M. A.
    Mendoza, C. Zepeda
    Vaubel, R.
    Nguyen, A. T.
    Trejo-Lopez, J. A.
    Raghunathan, A.
    Jenkins, S.
    Jenkins, R.
    Giannini, C.
    [J]. BRAIN PATHOLOGY, 2023, 33
  • [4] Comparing loss of p16 and MTAP expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma
    Vizcaino, M. Adelita
    Giannini, Caterina
    Vaubel, Rachael A.
    Nguyen, Aivi T.
    Trejo-Lopez, Jorge A.
    Raghunathan, Aditya
    Jenkins, Sarah M.
    Jenkins, Robert B.
    Mendoza, Cinthya J. Zepeda
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024,
  • [5] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
    Tang, Vivian
    Lu, Rufei
    Mirchia, Kanish
    Van Ziffle, Jessica
    Devine, Patrick
    Lee, Julieann
    Phillips, Joanna J. J.
    Perry, Arie
    Raleigh, David R. R.
    Lucas, Calixto-Hope G.
    Solomon, David A. A.
    [J]. ACTA NEUROPATHOLOGICA, 2023, 145 (04) : 497 - 500
  • [6] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
    Vivian Tang
    Rufei Lu
    Kanish Mirchia
    Jessica Van Ziffle
    Patrick Devine
    Julieann Lee
    Joanna J. Phillips
    Arie Perry
    David R. Raleigh
    Calixto-Hope G. Lucas
    David A. Solomon
    [J]. Acta Neuropathologica, 2023, 145 : 497 - 500
  • [7] Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting CDKN2A/B status
    Tosefsky, Kira
    Martin, Karina Chornenka
    Rebchuk, Alexander D.
    Wang, Justin Z.
    Nassiri, Farshad
    Lum, Amy
    Zadeh, Gelareh
    Makarenko, Serge
    Yip, Stephen
    [J]. NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [8] p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances
    Geyer, Lucas
    Wolf, Thibaut
    Chenard, Marie-Pierre
    Cebula, Helene
    Schott, Roland
    Noel, Georges
    Guerin, Eric
    Pencreach, Erwan
    Reita, Damien
    Entz-Werle, Natacha
    Lhermitte, Benoit
    [J]. CANCERS, 2023, 15 (05)
  • [9] Investigating the Use of p16 Immunohistochemistry as a Surrogate Marker for CDKN2A/B Homozygous Deletion in Astrocytomas
    Cho, Benjamin
    Umphlett, Melissa
    Tsankova, Nadejda
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 572 - 573
  • [10] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in higher-grade meningiomas
    Tang, Vivian
    Lucas, Calixto-Hope
    Lu, Rufei
    Mirchia, Kanish
    Sullivan, Daniel
    Van Ziffle, Jessica
    Devine, Patrick
    Lee, Julieann
    Phillips, Joanna
    Perry, Arie
    Raleigh, David
    Solomon, David
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 469 - 470